TabletsTablets
Schedule H (Prescription Required)Antidepressants & Mood StabilizersCode: 1928

Citalopram Tablets 20mg

Generic Formulation:Citalopram Tablets IP 20mg
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹18.75
Brand Estimate*
₹55.19
Estimated Savings:₹36.44 (66% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Citalopram is a racemic bicyclic phthalane derivative selective serotonin reuptake inhibitor (SSRI). It potently and selectively blocks the neuronal reuptake of serotonin (5-HT) in the central nervous system, enhancing serotonergic neurotransmission. Indicated for the treatment of major depressive disorder.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 1928.Report inaccuracy

Usage Guidelines

Take orally once daily in the morning or evening with water, with or without food. Maintain regular dosing schedule. Taper gradually when discontinuing.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Nausea, dry mouth, somnolence, insomnia, diaphoresis, tremor, sexual dysfunction. Rare/Severe: Boxed warning: Suicidal ideation; dose-dependent QT interval prolongation and torsades de pointes, serotonin syndrome, and hyponatremia.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Black box warning for suicidality in young patients. Maximum dose is capped at 40 mg/day (or 20 mg/day in elderly/hepatic patients) due to dangerous QT prolongation. Contraindicated in congenital long QT syndrome and concurrent MAOIs.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.